Human serum albumin-mimetic chromatography based hexadecyltrimethylammonium bromide as a novel direct probe for protein binding of acidic drugs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 114, Issue , 2015, Pages 1-7

  Salary, Mina ^a   Hadjmohammadi, Mohammadreza ^a  

^a UNIVERSITY OF MAZANDARAN   (Iran)

Author keywords

Biopartitioning micellar chromatography; Hexadecyltrimethylammonium bromide; Human serum albumin; Polynomial model; Protein drug binding

Indexed keywords

CEFTRIAXONE; CELECOXIB; CETRIMIDE; DICLOFENAC; FLUMEQUINE; FUROSEMIDE; GEMFIBROZIL; HUMAN SERUM ALBUMIN; IBUPROFEN; INDOMETACIN; MEFENAMIC ACID; NALIDIXIC ACID; NAPROXEN; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; SALICYLIC ACID; TOLMETIN; WARFARIN; ACID; MICELLE; PLASMA PROTEIN; PROTEIN BINDING; SERUM ALBUMIN; SOLVENT; SURFACTANT;

ARTICLE; BIOPARTITIONING MICELLAR CHROMATOGRAPHY; DRUG PROTEIN BINDING; IN VITRO STUDY; MICELLAR LIQUID CHROMATOGRAPHY; MICELLE; PH; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; ALGORITHM; BODY TEMPERATURE; CALIBRATION; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; CONFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; PRECLINICAL STUDY; PROCEDURES; REPRODUCIBILITY;

ACIDS; ALGORITHMS; BLOOD PROTEINS; BODY TEMPERATURE; CALIBRATION; CETRIMONIUM COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DRUG EVALUATION, PRECLINICAL; HUMANS; HYDROGEN-ION CONCENTRATION; MICELLES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; SOFTWARE; SOLVENTS; SURFACE-ACTIVE AGENTS;

EID: 84929309611     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2015.04.040     Document Type: Article

References (47)

1. Wan H., Rehngren M. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry. J. Chromatogr. A 2006, 1102:125-134.
2. Herve F., Urien S., Albengres E., Duche J.C., Tillement J.P. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clin. Pharmacokinet. 1994, 26:44-58.
3. Colmenarejo G. In silico prediction of drug-binding strengths to human serum albumin. Med. Res. Rev. 2003, 23:275-301.
4. Valko K., Nunhuck S., Bevan C., Abraham M.H., Reynolds D.P. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. J. Pharm. Sci. 2003, 92:2236-2248.
5. Goodman G.A., Gilman The Pharmacological Basis of Therapeutics 1996, McGraw-Hill, New York. 9th ed.
6. Chrysanthakopoulos M., Giaginis C., Tsantili-Kakoulidou A. Retention of structurally diverse drugs in human serum albumin chromatography and its potential to simulate plasma protein binding. J. Chromatogr. A 2010, 1217:5761-5768.
7. Morris J.J., Bruneau P.P. Prediction of physicochemical properties. Virtual Screening for Bioactive Compounds 2000, 33-56. Wiley-VCH Verlag GmbH, Weinheim. H.-J. Boehm, H. Schneider (Eds.).
8. Pehourcq F.D.-M., Radouane A., Labat L., Bannwarth B. Influence of lipophilicity on the protein binding affinity of cephalosporins. Pharm. Res. 1995, 12:1535-1538.
9. Colmenarejo G., Alvarez-Pedraglio A., Lavandera J.L. Cheminformatic models to predict binding affinities to human serum albumin. J. Med. Chem. 2001, 44:4370-4378.
10. Pinkerton T.C., Koeplinger K.A. Determination of Warfarin-human serum albumin protein binding parameters by an improved Hummel-Dreyer high-performance liquid chromatographic method using internal surface reversed-phase columns. Anal. Chem. 1990, 62:2114-2122.
11. Shibukawa A., Kuroda Y., Nakagawa T. High-performance frontal analysis for drug-protein binding study. J. Pharm. Biomed. Anal. 1999, 18:1047-1055.
12. Domenici E., Bertucci C., Salvadori P., Motellier S., Wainer I.W. Immobilized serum albumin: rapid HPLC probe of stereoselective protein-binding interactions. Chirality 1990, 2:263-268.
13. Beaudry F., Coutu M., Brown N.K. Determination of drug-plasma protein binding using human serum albumin chromatographic column and multiple linear regression model. Biomed. Chromatogr. 1999, 13:401-406.
14. Allenmark S., Bomgren B., Boren H. Direct liquid chromatographic separation of enantiomers on immobilized protein stationary phases: III. Optical resolution of a series of N-aroyl d,l-amino acids by high-performance liquid chromatography on bovine serum albumin covalently bound to silica. J. Chromatogr. 1983, 264:63-68.
15. Salary M., Ebrahimi P., Hadjmohammadi M.R. SDS-based biomembrane mimetic chromatography for prediction of human drug transport as an in vitro technique. Chromatographia 2013, 76:757-765.
16. Zhang N., Li Z., Che W., Xu S., Wang S. Biopartitioning micellar chromatography to predict dihydropyridine selective calcium channel antagonist toxicity. Chromatographia 2009, 70:685-690.
17. Escuder-Gilabert L., Molero-Monfort M., Villanueva-Camañas R.M., Sagrado S., Medina-Hernández M.J. Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier. J. Chromatogr. B 2004, 807:193-201.
18. Martínez-Pla J.J., Martín-Biosca Y., Sagrado S., Villanueva-Camañas R.M., Medina-Hernández M.J. Evaluation of the pH effect of formulations on the skin permeability of drugs by biopartitioning micellar chromatography. J. Chromatogr. A 2004, 1047:255-262.
19. Martínez-Pla J.J., Sagrado S., Villanueva-Camañas R.M., Medina-Hernández M.J. Retention-property relationships of anticonvulsant drugs by biopartitioning micellar chromatography. J. Chromatogr. B 2001, 757:89-99.
20. Quiñones-Torrelo C., Sagrado S., Villanueva-Camañas R.M., Medina-Hernández M.J. Opioid analgetics retention-pharmacologic activity models using biopartitioning micellar chromatography. J. Chromatogr. B 2002, 766:265-277.
21. Espluges J. Perspetivas Terapéuticas Con Su Fundamento Farmacológico, Farmacología General 1982, vol. II. Fundación García Muñoz-Sección SABER, Valencia.
22. Eriksson M.A.L., Gabrielsson J., Nilsson L.B. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis. J. Pharm. Biomed. Anal. 2005, 38:381-389.
23. de Jong L.A.A., Uges D.R.A., Franke J.P., Bischoff R. Receptor-ligand binding assays: technologies and applications. J. Chromatogr. B 2005, 829:1-25.
24. Parikh H.H., McElwain K., Balasubramanian V., Leung W., Wong D., Morris M.E., Ramanathan M. A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening. Pharm. Res. 2000, 17:632-637.
25. Escuder-Gilabert L., Martínez-Pla J.J., Sagrado S., Villanueva-Camañas R.M., Medina-Hernández M.J. Biopartitioning micellar separation methods: modelling drug absorption. J. Chromatogr. B 2003, 797:21-35.
26. Hadjmohammadi M.R., Salary M. Biopartitioning micellar chromatography with sodium dodecyl sulfate as a pseudo α1-acid glycoprotein to the prediction of protein-drug binding. J. Chromatogr. B 2013, 912:50-55.
27. Wold S. Cross-validatory estimation of the number of components in factor analysis and principal components models. Technometrics 1978, 20:397-406.
28. Cramer R.D., Patterson D.E., Bunce J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110:5959-5967.
29. Osten D.W. Selection of optimal regression models via cross-validation. J. Chemom. 1988, 2:39-48.
30. Berthod A., Girard I., Gonnet C. Additive effects on surfactant adsorption and ionic solute retention in micellar liquid chromatography. Anal. Chem. 1986, 58:1362-1367.
31. Brunton L.L., Chabner B.A., Knollmann B.C. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2011, McGraw-Hill, New York. 12th ed.
32. Sweetman S.C. Martindale: The Complete Drug Reference 2009, Pharmaceutical Press, London. 36th ed.
33. Österberg T., Svensson M., Lundahl P. Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids. Eur. J. Pharm. Sci. 2001, 12:427-439.
34. Cuenca-Benito M., Sagrado S., Villanueva-Camañas R.M., Medina-Hernández M.J. Quantitative retention-structure and retention-activity relationships of barbiturates by micellar liquid chromatography. J. Chromatogr. A 1998, 814:121-132.
35. Dabrowska M., Starek M., Skuciński J. Lipophilicity study of some non-steroidal anti-inflammatory agents and cephalosporin antibiotics: a review. Talanta 2011, 86:35-51.
36. Barbato F., di Martino G., Grumetto L., La Rotonda M.I. Retention of quinolones on human serum albumin and α1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity. Eur. J. Pharm. Sci. 2007, 30:211-219.
37. Obata K., Sugano K., Saitoh R., Higashida A., Nabuchi Y., Machida M., Aso Y. Prediction of oral drug absorption in humans by theoretical passive absorption model. Int. J. Pharm. 2005, 293:183-192.
38. Peters T. All About Albumin: Biochemistry, Genetics, and Medical Applications 1996, Academic Press, San Diego, CA, USA.
39. Ascenzi P., Fanali G., Fasano M., Pallottini V., Trezza V. Clinical relevance of drug binding to plasma proteins. J. Mol. Struct. 2014, 1077:4-13.
40. Hesami Takallu S., Rezaei Tavirani M., Kalantari S., Amir Bakhtiarvand M., Mahdavi S.M. Co-amoxiclav effects on the structural and binding properties of human serum albumin. Iran. J. Pharm. Res. 2010, 9(3):251-257.
41. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5Å resolution. Protein Eng. 1999, 12:439-446.
42. Ràfols C., Zarza S., Bosch E. Molecular interactions between some non-steroidal anti-inflammatory drugs (NSAID's) and bovine (BSA) or human (HSA) serum albumin estimated by means of isothermal titration calorimetry (ITC) and frontal analysis capillary electrophoresis (FA/CE). Talanta 2014, 130:241-250.
43. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 1992, 358:209-215.
44. Ruiz-Ángel M.J., Carda-Broch S., Torres-Lapasió J.R., García-Álvarez-Coque M.C. Retention mechanisms in micellar liquid chromatography. J. Chromatogr. A 2009, 1216:1798-1814.
45. Yin C., Ma L., Huang J., Xu L., Shi Z. Fast profiling ecotoxicity and skin permeability of benzophenone ultraviolet filters using biopartitioning micellar chromatography based on penetrable silica spheres. Anal. Chim. Acta 2013, 804:321-327.
46. Zhang S.L., Yao H., Wang C., Tam K.Y. Study the interactions between human serum albumin and two antifungal drugs: fluconazole and its analogue DTP. Bioorg. Med. Chem. Lett. 2014, 24:4963-4968.
47. Banker M.J., Clark T.H. Plasma/serum protein binding determinations. Curr. Drug Metab. 2008, 9:854-859.